HL

Hem Lata Phoolia

Active Director Director DIN 08394362
DIN 08394362 First appointment Mar 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Hem Lata Phoolia

Data last updated:

Hem Lata Phoolia is a Director at Schelling Pharma Private Limited (since 2019). The company operates in Trading. Schelling Pharma Private Limited reported revenue of ₹21.7 Lakh (FY 2023).

DIN 08394362
Primary Designation Director
Industry Trading
First Appointment 19 Mar 2019
Oldest Company Age 7 yrs
Largest company Schelling Pharma Private Limited · ₹21.7 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Schelling Pharma Private Limited U51909RJ2019PTC064320
Director19 Mar 20192019₹21.7 Lakh (FY 2023)Active

Board colleagues of Hem Lata Phoolia

Directorship timeline

Open interactive timeline →
Schelling Pharma Private Limited
Premium access

Shareholding and investment profile for Hem Lata Phoolia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hem Lata Phoolia

Hem Lata Phoolia currently holds 1 directorship: Schelling Pharma Private Limited (Director, since 19 Mar 2019, revenue ₹21.7 Lakh (FY 2023)).

Hem Lata Phoolia was first appointed on 19 Mar 2019 as Director at Schelling Pharma Private Limited.

The current boards of Hem Lata Phoolia's companies include Naresh Kumar Anand (Schelling Pharma Private Limited), Ved Prakash Ahuja (Schelling Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available